National Comprehensive Cancer Network Prostate Cancer Risk Stratification for Clinically Localized Disease

**Semantic type:** Intellectual Product

**Definition:** A prostate cancer risk stratification system developed by the National Comprehensive Cancer Network that utilizes clinical tumor stage, Gleason grade, serum prostate specific antigen level, and other factors, including the percentage of positive biopsy cores, to select appropriate treatment options and predict the probability of biochemical recurrence after definitive local therapy.

**Synonyms:** - NCCN Prostate Cancer Risk Classification - NCCN Prostate Cancer Risk Stratification for Clinically Localized Disease